Natural Killer (NK) Cells With HLA Compatible Hematopoietic Transplantation for High Risk Myeloid Malignancies
Condition: Leukemia
Interventions: Drug: Busulfan; Drug: Fludarabine; Procedure: Alloreactive NK infusion; Drug: Interleukin-2; Procedure: Stem Cell Infusion; Drug: G-CSF; Drug: Tacrolimus; Drug: Methotrexate
Sponsors: M.D. Anderson Cancer Center; Cancer Prevention Research Institute of Texas; CML Program Project Grant
Recruiting - verified September 2016
Interventions: Drug: Busulfan; Drug: Fludarabine; Procedure: Alloreactive NK infusion; Drug: Interleukin-2; Procedure: Stem Cell Infusion; Drug: G-CSF; Drug: Tacrolimus; Drug: Methotrexate
Sponsors: M.D. Anderson Cancer Center; Cancer Prevention Research Institute of Texas; CML Program Project Grant
Recruiting - verified September 2016